Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/16/2012CN102451168A Preparation method of naringenin tablet
05/16/2012CN102451167A H1 accepter antagonist oral cavity disintegrating tablet and preparation method thereof
05/16/2012CN102451166A Setron medicament oral cavity disintegrating tablet and preparation method thereof
05/16/2012CN102451165A Rotundine orally disintegrating tablets and preparation method thereof
05/16/2012CN102451164A Analgesic oral cavity disintegrating tablet and preparation method thereof
05/16/2012CN102451163A Polyporus polysaccharide dispersible tablets, and preparation method thereof
05/16/2012CN102451162A Olanzapine medicine absorbed through oral mucosa
05/16/2012CN102451161A Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
05/16/2012CN102451160A Preparation method of long-circulating nanoparticle
05/16/2012CN102451159A Superfine vinpocetine composite particle and preparation method thereof
05/16/2012CN102451158A Nimodipine-SiO2 nanospheres and preparation and application thereof
05/16/2012CN102451157A Docetaxel submicron emulsion with steroid composite as intermediate carrier
05/16/2012CN102451156A Gemcitabine hydrochloride injection preparation and its preparation method
05/16/2012CN102451155A Prescription and preparation method of docetaxel injection
05/16/2012CN102451154A Netilmicin sulfate injection and preparation method thereof
05/16/2012CN102451112A Oral cavity refreshing dripping pills with functions of inflammation eliminating and hemostasis, and preparation method thereof
05/16/2012CN102450653A Animal spleen dry powder
05/16/2012CN102078291B Method for preparing iron sorbitex injection
05/16/2012CN102058687B Qingpeng oral formulation for easing pain and reducing swelling and preparation method thereof
05/16/2012CN101977610B Methods of treating viral infections
05/16/2012CN101934015B Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof
05/16/2012CN101926508B Application of blackberrykiky rhizome in cigarette
05/16/2012CN101756895B Polyene phosphatidyl choline intravenous preparation and preparation method thereof
05/16/2012CN101574507B Nasal administration system for treating headache
05/16/2012CN101524470B Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof
05/16/2012CN101524404B Enteric sustained and controlled release capsule
05/16/2012CN101513400B Ampelopsin and basic amino acid solubilizing system and antitumor activity research
05/16/2012CN101327016B Ultramicro ginger powder and method for producing the same
05/16/2012CN101306019B Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
05/16/2012CN101262850B Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
05/16/2012CN101147725B Ketoconazole suppository composition for vaginal administration
05/16/2012CN101070536B Inducing expression of hepatitis-B virus cytomembrane small-protein and middle-protein gene in clover
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178656 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents
05/15/2012US8178597 Aqueous inkjet recording ink and method for producing the same
05/15/2012US8178576 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
05/15/2012US8178519 Antiinflammatory agents; heating glucocorticoid with water and surfactant
05/15/2012US8178518 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
05/15/2012US8178499 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178498 Medicament and method of treating an organism with medicaments
05/15/2012US8178129 Gagomer particles by reacting hyaluronic acid with dilauryl phosphatidyl ethanolamine lipid; encapsulate water insoluble paclitaxel, drugs; cancer
05/15/2012US8178128 Nanoparticles containing polymeric nucleic acid homologs
05/15/2012US8178127 with an antioxidant and carrier; chemical stability; storage stability; validating a batch of a laquinimod product by determination if specified undesirable by-products are present
05/15/2012US8178125 Oral formulations of glycyl-2-methylprolyl-glutamate
05/15/2012US8178124 Drug carrier and drug carrier kit for inhibiting fibrosis
05/15/2012US8178121 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
05/15/2012US8178115 Method and composition for the treatment of scars
05/15/2012US8178112 Ketoprofen compositions and methods of making them
05/15/2012US8178099 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage
05/15/2012US8178098 Administering to the lungs of mammal an aerosolized antibody formulation comprising antibodies that selectively bind to a receptor on a T cell to reduce airway hyperresponsiveness
05/15/2012US8177775 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique
05/15/2012US8177739 Rapid infusion system
05/15/2012CA2717605C Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
05/15/2012CA2680675C Sonophoresis skin care device
05/15/2012CA2670821C Osmotic delivery systems and piston assemblies
05/15/2012CA2640743C Pharmaceutical composition of microspheres for preventing diabetic limb amputation
05/15/2012CA2624810C Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
05/15/2012CA2593016C Taste masking system for non-plasticizing drugs
05/15/2012CA2556922C Polymeric compositions and dosage forms comprising the same
05/15/2012CA2543353C Oral drug delivery system
05/15/2012CA2542726C Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/15/2012CA2541779C Form of administration based on crosslinked hydrophilic polymers
05/15/2012CA2536281C Ophthalmic composition comprising a 15-keto-prostaglandin compound
05/15/2012CA2526616C Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
05/15/2012CA2511849C Stable topical drug delivery compositions comprising a multilamellar liquid crystal phosphatidylcholine carrier
05/15/2012CA2482787C Temperature responsive delivery systems
05/15/2012CA2479351C Topical composition comprising a cyclofructan, a carrier and a drug
05/15/2012CA2478553C Probiotic delivery system
05/15/2012CA2477593C Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases
05/15/2012CA2470500C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
05/15/2012CA2464471C Method of treating depression with delta receptor agonist compounds
05/15/2012CA2461730C Novel cyclosporin analog microemulsion preconcentrates
05/15/2012CA2437899C Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
05/15/2012CA2433679C Polymer coated microparticles for sustained release
05/15/2012CA2430816C Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
05/15/2012CA2402169C Formulation and method for treating neoplasms by inhalation
05/15/2012CA2398229C Improved dna vaccines for production-type animals
05/15/2012CA2365536C Compositions and methods for improved delivery of hydrophobic therapeutic agents
05/15/2012CA2207641C Hot melt adhesive composition containing antimicrobial compound
05/10/2012WO2012061833A1 Compositions and methods for treating myelofibrosis
05/10/2012WO2012061787A1 A2a antagonists as cognition and motor function enhancers
05/10/2012WO2012061779A1 Drug formulations
05/10/2012WO2012061703A1 Compositions and methods relating to reduced mucoadhesion
05/10/2012WO2012061547A1 System and method for differentially timed local delivery of a combination pharmaceutical preparation for oral therapy
05/10/2012WO2012061480A2 Compositions and methods for the delivery of therapeutics
05/10/2012WO2012061402A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012WO2012061377A1 Bioerodible silicon-based devices for delivery of therapeutic agents
05/10/2012WO2012061193A2 Magnetic targeting device, system and method
05/10/2012WO2012061061A1 Pharmaceutical formulations of a substituted diaminopurine
05/10/2012WO2012060832A1 Skin wound healing compositions and methods of use thereof
05/10/2012WO2012060793A2 Process for the preparation of cefdinir formulations
05/10/2012WO2012060792A1 Pharmaceutical compositions comprising minimum 6 % of disintegrants by weight
05/10/2012WO2012060791A2 Production method for pharmaceutical compositions comprising cefdinir
05/10/2012WO2012060790A2 Water dispersible cefpodoxime proxetil formulations
05/10/2012WO2012060789A2 Production method for cefdinir formulations
05/10/2012WO2012060788A1 Formulations of cephalosporins with controlled moisture content
05/10/2012WO2012060787A1 Oral dosage forms comprising cefdinir and carboxymethyl cellulose calcium
05/10/2012WO2012060786A2 Cefpodoxime proxetil formulations comprising viscosity agent
05/10/2012WO2012060785A1 Production method for tablets comprising cephalosporin
1 ... 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 ... 2991